Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201307059 Principal Investigator: Tan, Benjamin
Title: A Multicenter, Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma
Phase: III Disease Site: Liver
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The main purpose of this study is to find out whether patients with hepatocellular carcinoma who receive lenvatinib live longer compared to patients who receive sorafenib.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)